CORC  > 山东大学
Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer
Chen, Ping; Luo, Shan; Wen, Yan-Jun; Li, Yu-Hua; Li, Jiong; Wang, Yong-Sheng; Du, Li-Cheng; Zhang, Ping; Tang, Jiao; Yang, Da-Bing
刊名CANCER SCIENCE
2014
卷号105期号:11页码:1393-1401
关键词Angiogenesis CCL21 cytotoxic T lymphocytes immunotherapy paclitaxel
DOI10.1111/cas.12537
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4794238
专题山东大学
作者单位1.[Chen, Ping
2.Luo, Shan
3.Wen, Yan-Jun
4.Li, Yu-Hua
5.Li, Jiong
6.Wang, Yong-Sheng
7.Du, Li-Cheng
8.Zhang, Ping
9.Tang, Jiao
10.Yang, Da-Bing
推荐引用方式
GB/T 7714
Chen, Ping,Luo, Shan,Wen, Yan-Jun,et al. Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer[J]. CANCER SCIENCE,2014,105(11):1393-1401.
APA Chen, Ping.,Luo, Shan.,Wen, Yan-Jun.,Li, Yu-Hua.,Li, Jiong.,...&Geng D.(2014).Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer.CANCER SCIENCE,105(11),1393-1401.
MLA Chen, Ping,et al."Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer".CANCER SCIENCE 105.11(2014):1393-1401.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace